A rating of 98 puts Protagonist Therapeutics Inc (PTGX) near the top of the Biotechnology industry according to InvestorsObserver. Protagonist Therapeutics Inc's score of 98 means it scores higher than 98% of stocks in the industry. Protagonist Therapeutics Inc also received an overall rating of 71, putting it above 71% of all stocks. Biotechnology is ranked 107 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 71 would rank higher than 71 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Protagonist Therapeutics Inc Stock Today?
Protagonist Therapeutics Inc (PTGX) stock is up 5.82% while the S&P 500 is lower by -0.03% as of 9:58 AM on Wednesday, Jun 16. PTGX has risen $2.22 from the previous closing price of $38.15 on volume of 355,335 shares. Over the past year the S&P 500 is up 35.86% while PTGX has risen 144.82%. PTGX lost -$1.82 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Protagonist Therapeutics Inc (PTGX) Stock.
